Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,864,157,359
+$992,143,557 QoQ
Shares Held
15,215,015
+29.5% QoQ
Ownership
0.631%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#24
of 4,676 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital World Investors holds $50,250,725,849 across 10 Drug Manufacturers - General names. JNJ ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,902,642 | $19,074,107,484 | |
| 2 | AMGN |
Amgen Inc
|
29,075,329 | $10,528,758,137 | |
| 3 | AZN |
Astrazeneca PLC
|
30,075,134 | $5,702,846,909 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,988,975 | $5,178,547,101 | |
| 5 | ABBV |
AbbVie Inc.
|
19,178,966 | $4,826,195,004 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
15,215,015 | $3,864,157,359 | |
| 7 | PFE |
Pfizer Inc
|
22,218,190 | $535,014,015 | |
| 8 | NVO |
Novo Nordisk A S
|
5,205,926 | $249,572,092 |
All Filings in JNJ
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,864,157,359 | 15,215,015 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,872,013,802 | 11,749,361 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,005,942,343 | 9,692,884 | Shares | Defined | 2026-02-11 | |
| 2023-09-30 | $358,101,490 | 2,299,207 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $996,518,622 | 6,020,533 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,102,718,050 | 7,114,310 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,733,060,508 | 9,810,702 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,710,860,785 | 10,472,948 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,821,887,730 | 10,263,578 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,712,259,615 | 9,661,229 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $1,761,156,412 | 10,294,946 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,660,778,951 | 10,283,461 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,932,136,780 | 11,728,401 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,958,869,242 | 11,918,888 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,682,217,027 | 23,396,982 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,464,985,329 | 23,273,679 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,250,377,533 | 23,112,974 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,779,430,037 | 21,195,989 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||